XML 17 R7.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 9 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Cash Flows From Operating Activities:    
Net loss $ (18,093,349) $ (13,427,457)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock-based compensation expense 993,114 554,228
Issuance of common stock for services 68,000 428,770
Amortization of operating lease right-of-use asset 121,339 112,605
Depreciation 761 632
Changes in operating assets and liabilities:    
Prepaid expenses (1,149,158) (3,471)
Deposits 19,031
Accounts payable (501,571) (901,918)
Accrued expenses 202,696 (82,361)
Accrued compensation (115,106) (180,374)
Accrued interest (87,996) 12,216
Operating lease liability (117,145) (85,736)
Net Cash Used In Operating Activities (18,659,384) (13,572,866)
Cash Flows Used in Investing Activities:    
Purchase of property and equipment (6,938) (1,831)
Net Cash Used In Operating Activities (6,938) (1,831)
Cash Flows From Financing Activities:    
Proceeds from note payable – paycheck protection program 164,583
Principal paid on notes payable – related parties (172,970)
Proceeds from sale of NoveCite, Inc. common stock 500
Net proceeds from private placement 18,450,410
Net proceeds from registered direct offering 70,979,842 6,877,100
Net proceeds from common stock warrant exercises 31,130,134 7,156,549
Net proceeds from common stock option exercises 82,634
Net Cash Provided By Financing Activities 120,470,550 14,198,232
Net Change in Cash and Cash Equivalents 101,804,228 623,535
Cash and Cash Equivalents - Beginning of Period 13,859,748 7,893,804
Cash and Cash Equivalents - End of Period 115,663,976 8,517,339
Supplemental Disclosures Of Cash Flow Information and Non-cash Activities:    
Operating lease right-of-use asset and liability recorded upon adoption of ASC 842 $ 1,137,724